Literature DB >> 11406730

Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk.

D Mukherjee1, D P Chew, M Robbins, J S Yadav, R E Raymond, D J Moliterno.   

Abstract

The goal of platelet function testing in the catheterization laboratory is to provide information about the platelet contributions to the risk of thrombotic or hemorrhagic events and optimization of anti-platelet therapy for percutaneous interventions. We present several illustrative cases in which platelet monitoring with the Rapid Platelet Function Assay (RPFA, Accumetrics) was used to guide dosing of a glycoprotein (GP) IIb/IIIa inhibitor for coronary and peripheral intervention among patients at increased bleeding risk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406730     DOI: 10.1023/a:1011228817265

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  7 in total

Review 1.  Applications of anti-platelet monitoring in catheterization laboratory.

Authors:  D Mukherjee; D J Moliterno
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

Review 2.  Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study.

Authors:  S R Steinhubl
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

3.  Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.

Authors:  E J Topol; J J Ferguson; H F Weisman; J E Tcheng; S G Ellis; N S Kleiman; R J Ivanhoe; A L Wang; D P Miller; K M Anderson; R M Califf
Journal:  JAMA       Date:  1997-08-13       Impact factor: 56.272

4.  Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade.

Authors:  B S Coller; D Lang; L E Scudder
Journal:  Circulation       Date:  1997-02-18       Impact factor: 29.690

Review 5.  Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.

Authors:  A M Lincoff; R M Califf; E J Topol
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

6.  Rapid platelet-function assay: an automated and quantitative cartridge-based method.

Authors:  J W Smith; S R Steinhubl; A M Lincoff; J C Coleman; T T Lee; R S Hillman; B S Coller
Journal:  Circulation       Date:  1999-02-09       Impact factor: 29.690

Review 7.  Platelet GPIIb-IIIa blockers.

Authors:  E J Topol; T V Byzova; E F Plow
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

  7 in total
  2 in total

Review 1.  Assessment of platelet inhibition by point-of-care testing in neuroendovascular procedures.

Authors:  H M Hussein; T Emiru; A L Georgiadis; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

2.  Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel.

Authors:  Joel G Ray; Stacy Deniz; Anthony Olivieri; Erika Pollex; Marian J Vermeulen; Kurian S Alexander; David J Cain; Irene Cybulsky; Cindy M Hamielec
Journal:  BMC Cardiovasc Disord       Date:  2003-05-22       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.